900m lives depend on livestock

GALVmed makes livestock vaccines, medicines and diagnostics accessible and affordable to the millions in developing countries for whom livestock is a lifeline

About GALVmed

Brucellosis is a costly disease that affects cattle, sheep and goats and causes abortions, infertility, decreased milk production and weight loss.

The annual impact of Brucellosis to smallholder farmers in South Asia and Sub-Saharan Africa is estimated at US $501 million per year.

There are approximately 500,000 new human cases of Brucellosis reported annually.

A US $30 million prize competition was created to incentivise the private sector in producing a B. melitensis vaccine.

Find out more about the US $30 million prize competition

Our work

Product development

GALVmed specialises in product development partnerships uniquely established to translate global research progress into tangible livestock disease control tools for the developing world.

Market development

Our work with our partners supports the poor livestock keepers of the world.

Policy and advocacy

The policy environment is a key determinant in the successful translation of research products to livestock health solutions that are sustainably available to smallholder farmers.


Vaccinating poultry empowers women in rural India #BeBoldForChange

Today, 8th March, the world celebrates International Women’s Day, which is an important catalyst and vehicle for driving greater change for women while moving closer to gender equality.

This year’s International Women’s Day campaign theme is …

New vaccine brings hope to north Cameroon

A project in Cameroon’s drought-stricken northern region is enabling an increasing number of farmers to take up traditional poultry keeping. In the villages of Bibemi and Djola in Garoua, regular access to the I-2 Newcastle …

Researchers on a mission to improve the East Coast Fever vaccine

GALVmed recently held a workshop Nairobi (19-20 January 2017) to discuss ongoing research to improve the East Coast Fever (ECF) vaccine. The vaccine, commonly known as Infection and Treatment Method (ITM)  was developed in mid-70s …